 Connection
Michael Bristow to United States Food and Drug Administration
This is a "connection" page, showing publications Michael Bristow has written about United States Food and Drug Administration.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.356 |
|
|
|
-
Bristow MR, Hiatt WR. The FDA regulatory process for drug and genetic diagnostic test approvals. Clin Transl Sci. 2008 Dec; 1(3):188-9.
Score: 0.277
-
Blumer V, Januzzi JL, Lindenfeld J, Solomon SD, Psotka MA, Carson PE, Bristow MR, Abraham WT, Gandotra C, Saville BR, O'Connor C, Fiuzat M. Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory. JACC Heart Fail. 2024 Nov; 12(11):1803-1813.
Score: 0.051
-
Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, Bristow MR, Packer M, Wasserman SM, Braunstein N, Pitt B, DeMets DL, Cooper-Arnold K, Armstrong PW, Berkowitz SD, Scott R, Prats J, Galis ZS, Stockbridge N, Peterson ED, Califf RM. Cardiovascular drug development: is it dead or just hibernating? J Am Coll Cardiol. 2015 Apr 21; 65(15):1567-82.
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|